343 related articles for article (PubMed ID: 26953203)
1. Effects of Efflux Pump Inhibitors on Colistin Resistance in Multidrug-Resistant Gram-Negative Bacteria.
Ni W; Li Y; Guan J; Zhao J; Cui J; Wang R; Liu Y
Antimicrob Agents Chemother; 2016 May; 60(5):3215-8. PubMed ID: 26953203
[TBL] [Abstract][Full Text] [Related]
2. Effect of carbonyl cyanide 3-chlorophenylhydrazone (CCCP) on killing Acinetobacter baumannii by colistin.
Park YK; Ko KS
J Microbiol; 2015 Jan; 53(1):53-9. PubMed ID: 25557480
[TBL] [Abstract][Full Text] [Related]
3. Efflux pump inhibitor CCCP to rescue colistin susceptibility in mcr-1 plasmid-mediated colistin-resistant strains and Gram-negative bacteria.
Baron SA; Rolain JM
J Antimicrob Chemother; 2018 Jul; 73(7):1862-1871. PubMed ID: 29718423
[TBL] [Abstract][Full Text] [Related]
4. Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin.
Personne Y; Curtis MA; Wareham DW; Waite RD
J Antimicrob Chemother; 2014 Dec; 69(12):3236-43. PubMed ID: 25134721
[TBL] [Abstract][Full Text] [Related]
5. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
Doymaz MZ; Karaaslan E
Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
[No Abstract] [Full Text] [Related]
6. [Evaluation of sensi-disk elution for colistin susceptibility determination in multidrug resistant gramnegative bacilli].
Jofré M; Barrera B; Silva F; Berrocal L
Rev Chilena Infectol; 2020 Feb; 37(1):87-88. PubMed ID: 32730406
[TBL] [Abstract][Full Text] [Related]
7. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C
Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994
[TBL] [Abstract][Full Text] [Related]
8. Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme.
Yau W; Owen RJ; Poudyal A; Bell JM; Turnidge JD; Yu HH; Nation RL; Li J
J Infect; 2009 Feb; 58(2):138-44. PubMed ID: 19058855
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Etest method for detecting colistin susceptibility of multidrug-resistant Gram-negative isolates in Vietnam.
Nhung PH; Miyoshi-Akiyama T; Phuong DM; Shimada K; Anh NQ; Binh NG; Thanh do V; Ohmagari N; Kirikae T
J Infect Chemother; 2015 Aug; 21(8):617-9. PubMed ID: 25960156
[TBL] [Abstract][Full Text] [Related]
10. Colistin methanesulfonate against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
Kroeger LA; Hovde LB; Mitropoulos IF; Schafer J; Rotschafer JC
Antimicrob Agents Chemother; 2007 Sep; 51(9):3431-3. PubMed ID: 17576842
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.
Li J; Nation RL; Milne RW; Turnidge JD; Coulthard K
Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821
[TBL] [Abstract][Full Text] [Related]
12. Comparison of E-test and disc diffusion methods for the in vitro evaluation of the antimicrobial activity of colistin in multi-drug resistant Gram-negative Bacilli.
Somily AM
Saudi Med J; 2010 May; 31(5):507-11. PubMed ID: 20464039
[TBL] [Abstract][Full Text] [Related]
13. Alterations in AdeS and AdeR regulatory proteins in 1-(1-naphthylmethyl)-piperazine responsive colistin resistance of
Yilmaz Ş; Hasdemir U; Aksu B; Altınkanat Gelmez G; Söyletir G
J Chemother; 2020 Oct; 32(6):286-293. PubMed ID: 32131715
[TBL] [Abstract][Full Text] [Related]
14. Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumannii.
Martínez-Guitián M; Vázquez-Ucha JC; Odingo J; Parish T; Poza M; Waite RD; Bou G; Wareham DW; Beceiro A
Antimicrob Agents Chemother; 2016 Jul; 60(7):4375-9. PubMed ID: 27139471
[TBL] [Abstract][Full Text] [Related]
15. ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.
Tacconelli E; Mazzaferri F; de Smet AM; Bragantini D; Eggimann P; Huttner BD; Kuijper EJ; Lucet JC; Mutters NT; Sanguinetti M; Schwaber MJ; Souli M; Torre-Cisneros J; Price JR; Rodríguez-Baño J
Clin Microbiol Infect; 2019 Jul; 25(7):807-817. PubMed ID: 30708122
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the rapid ResaPolymyxin
Jung H; Pitout JDD; Mitton BC; Strydom KA; Kingsburgh C; Coetzee J; Ehlers MM; Kock M
J Med Microbiol; 2021 Jun; 70(6):. PubMed ID: 34165418
[No Abstract] [Full Text] [Related]
17. Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii.
Kuo HY; Chang KC; Kuo JW; Yueh HW; Liou ML
Int J Antimicrob Agents; 2012 Jan; 39(1):33-8. PubMed ID: 21996406
[TBL] [Abstract][Full Text] [Related]
18. Synergy of colistin with rifampin and trimethoprim/sulfamethoxazole on multidrug-resistant Stenotrophomonas maltophilia.
Giamarellos-Bourboulis EJ; Karnesis L; Giamarellou H
Diagn Microbiol Infect Dis; 2002 Nov; 44(3):259-63. PubMed ID: 12493173
[TBL] [Abstract][Full Text] [Related]
19. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.
Li J; Rayner CR; Nation RL; Owen RJ; Spelman D; Tan KE; Liolios L
Antimicrob Agents Chemother; 2006 Sep; 50(9):2946-50. PubMed ID: 16940086
[TBL] [Abstract][Full Text] [Related]
20. Activity of the colistin-rifampicin combination against colistin-resistant, carbapenemase-producing Gram-negative bacteria.
Nastro M; Rodríguez CH; Monge R; Zintgraff J; Neira L; Rebollo M; Vay C; Famiglietti A
J Chemother; 2014 Aug; 26(4):211-6. PubMed ID: 24070502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
